Business World

   Highlights :  For better national and international visibility : Panel recommends renaming India's Drug Regulator It has proposed three options. Government plans a major overhaul of the country's drug regulatory authority. F or better national and international visibility,  Panel recommends renaming India's Drug Regulatory Authority. The present nomenclature of Central Drugs Standard Control Organization does not reflect the true and extended functional character of the organisation.  It has proposed three options -  Central Medical Products Administration, India Central Medical Products Regulatory Agency, India National Medical Products Regulatory Agency, India The government plans a major overhaul of the country's drug regulatory authority in a bid to bring changes in line with global standards and to deliver services efficiently.